NEUROENDOCRINE TUMOUR METASTATIC

NEUROENDOCRINE TUMOUR METASTATIC was reported 9 times

NEUROENDOCRINE TUMOUR METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Somatostatin Analog [EPC] 1 0.0001
1 Protease Inhibitor [EPC] 1 0.0000
2 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
3 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
4 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
5 GLP-1 Receptor Agonist [EPC] 2 0.0000
6 Kinase Inhibitor [EPC] 1 0.0000